By continuing to use the site you agree to our Privacy & Cookies policy

Drug recommended by NICE for stroke prevention

The National Institute for Health and Clinical Excellence (NICE) has recommended the oral anticoagulant dabigatran (Pradaxa) as an option for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

Data showed dabigatran 150mg twice daily was more effective than warfarin, and 110mg twice daily was as effective as warfarin, NICE said.

It added that decisions on starting treatment with dabigatran should be made after discussion about its risks and benefits compared with warfarin, and in light of a patient’s current level of international normalised ratio control.

Have your say

You must sign in to make a comment.

Related Jobs

Sign in to see the latest jobs relevant to you!